IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#126
Positioning
Market Dominance
Manufacturing
Medical Equipment
$10.8B
Deepak S. Nath
Smith & Nephew plc develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products. It also provides sports medicine joint repair products for surgeons.
Headcount
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = SNN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$SNN SMITH & NEPHEW PLC | 69 | 86 | 91 | 52 | - | 3.1x | 31.3% | 15.9% | 70.7% | 9.8% | 7.2% | 3.7% | 3.0% | 0.0x | $10.8B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
SMITH & NEPHEW PLC (SNN) receives a "Buy" rating with a composite score of 68.9/100. It ranks #126 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Deepak S. Nath
Chief Executive Officer
Labor Force
20,100
86
46
92
Audit Verdict: High quality, disciplined capital allocation, and low volatility suggest strong governance.
No recent insider transactions available for SNN
20.1K
HQ Base
LONDON,
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for SNN.
View All RatingsConservative accounting — High cash conversion efficiency
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 86 | 99 | -13DRAG |
| MOMENTUM | 52 | 40 | +12ALPHA |
| VALUATION | 91 | 94 | -3NEUTRAL |
| INVESTMENT | 46 | 85 | -39DRAG |
| STABILITY | 92 | 95 | -3NEUTRAL |
| SHORT INT | 34 | 23 | +11ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 31.3% (sector -2.5%)
GM 71% vs sector 43%, OM 10% vs sector 1%
Capital turnover N/A, R&D intensity 5.0%
Rev growth 4%, 8yr history
Interest coverage 3.9x, Net debt/EBITDA -0.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
SMITH & NEPHEW PLC receives a Buy rating with a composite score of 68.9/100 and 4 out of 5 stars, ranking #126 of 7,333 stocks in our universe. SNN displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
SMITH & NEPHEW PLC scores an outstanding 86/100 on our quality factor, placing it among the highest-quality companies in our coverage universe. The company reports a return on equity of 31.3% (sector avg: -2.5%), gross margins of 70.7% (sector avg: 42.5%), net margins of 7.2% (sector avg: -0.2%). This level of profitability and capital efficiency typically reflects a durable competitive advantage and disciplined management.
From a valuation perspective, SNN scores an exceptional 91/100, indicating the stock trades at a deep discount relative to its fundamentals. Key valuation metrics include an EV/EBITDA of 3.12x, a P/B ratio of 2.91x. A value score this high suggests the market may be significantly underpricing the company's earnings power, assets, or cash flow generation.
With an investment score of 46/100, SNN exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 3.7% vs. a sector average of 5.9% and a return on assets of 15.9% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
SNN demonstrates moderate momentum with a score of 52/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 3.7% year-over-year, while a beta of 0.47 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
SMITH & NEPHEW PLC earns an excellent stability score of 92/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.47 and a debt-to-equity ratio of 0.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
SMITH & NEPHEW PLC's short interest score of 34/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. At $10.8B (large-cap), SNN carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
SNN pays a solid dividend yield of 3.0%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
SMITH & NEPHEW PLC is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #126 of 7,333 overall (98th percentile). Key comparisons include ROE of 31.3% exceeding the -2.5% sector median and operating margins of 9.8% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
Quant Factor Profile
Key factor gap
Stability (92) vs Short Int. (34) — closing this gap could shift the rating.
EV/EBITDA 73% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1362% BELOW SECTOR MEDIAN
Gross Margin 66% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF DEC 31, 2024 (Q3 FY2024)
We rate SMITH & NEPHEW PLC (SNN) as a Buy with a composite score of 68.9/100 at a current price of $35.98. The stock scores above average across the majority of our six quantitative factors and ranks #126 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in stability (92th percentile) and value (91th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (59/100), Low uncertainty, and Exemplary capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
SMITH & NEPHEW PLC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 68.9/100 places it at rank #126 in our full 7,333-stock universe. With a $10.8B market capitalization, SMITH & NEPHEW PLC operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue is growing at 4%, though momentum at the 52th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 71% (+28.2pp vs sector) narrow to operating margins of 10% (+8.5pp vs sector) and net margins of 7.2%, yielding a gross-to-net conversion rate of 10%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $35.98, SMITH & NEPHEW PLC appears undervalued relative to its fundamentals. Our value factor score of 91/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at EV/EBITDA of 3.1x (discounted to peers), P/B of 2.9x, P/S of 0.7x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock's Buy rating (composite score 68.9/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Gross margins of 71% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 31.3% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 91/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
A conservative balance sheet (0% D/E) provides financial flexibility for acquisitions, buybacks, or weathering economic downturns without dilution.
We assign a Low uncertainty rating to SMITH & NEPHEW PLC. The company exhibits strong financial stability with a beta of 0.47, conservative leverage (0% D/E), and a stability factor in the 92th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.47 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 92th percentile and quality factor at the 86th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 71% provide a buffer against cost pressures; conservative leverage (0% D/E) limits balance sheet risk; above-average stability (92th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate SMITH & NEPHEW PLC's capital allocation as Exemplary. Management demonstrates a strong track record of balancing reinvestment with shareholder returns, evidenced by returns on equity of 31.3%, disciplined leverage (0% D/E), a 3.05% dividend yield. Exemplary allocators typically generate returns on equity above 20% while maintaining debt-to-equity below 50% — SMITH & NEPHEW PLC meets this high bar.
The balance sheet remains conservatively managed, providing financial flexibility for opportunistic investments while maintaining a margin of safety for shareholders. The company returns capital via a 3.05% dividend yield, and the combination of 15.9% return on assets and controlled leverage suggests management is deploying capital at rates well above the cost of capital — the hallmark of exemplary stewardship.
In summary, SMITH & NEPHEW PLC receives a Buy rating with a composite score of 68.9/100 (rank #126 of 7,333). Our quantitative framework assigns a Narrow Moat (59/100, trend: stable), Low uncertainty, and Exemplary capital allocation. The average factor score across quality, value, momentum, stability, and investment is 73/100.
Our analysis supports a constructive view on SMITH & NEPHEW PLC. The combination of identifiable competitive advantages, low uncertainty, and exemplary capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign SMITH & NEPHEW PLC a Narrow Moat rating with a composite moat score of 59/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that SMITH & NEPHEW PLC can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being economic value creation at 18.6/20.
The strongest moat sources are economic value creation (18.6/20) and margin superiority (17.5/20). ROE proxy 31.3% (sector -2.5%). GM 71% vs sector 43%, OM 10% vs sector 1%. These pillars form the core of SMITH & NEPHEW PLC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (3/20) and growth durability (7.9/20). Capital turnover N/A, R&D intensity 5.0%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect SMITH & NEPHEW PLC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 71% providing a solid profitability foundation, returns on equity of 31.3% driving shareholder value creation. The margin cascade from 71% gross to 10% operating to 7.2% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 86th percentile.
The margin profile shows gross margins of 71%, operating margins of 10%, net margins of 7.2%. Return metrics include ROE of 31.3% and ROA of 15.9%. Relative to the Manufacturing sector, gross margins are 28.2 percentage points above the sector median of 43%, and ROE of 31.3% compares to a sector median of -2.5%.
The balance sheet reflects a conservatively managed balance sheet with D/E of 0%, a dividend yield of 3.05%, revenue growth of 4%. The sector median D/E is 0%, putting SMITH & NEPHEW PLC in a relatively stronger balance sheet position. Overall balance sheet health is adequate for the current business environment.
Even high-quality stocks face risks from valuation compression, competitive disruption, or macro shocks that are difficult to quantify in advance.
Above 50MA
37.18%
Net New Highs
+51081

Smith+Nephew has completed its acquisition of US-based Integrity Orthopaedics for an initial cash payment of $225 million, with potential performance-based payments up to an additional $225 million over five years. Integrity Orthopaedics specializes in rotator cuff repair technology, and this acquisition supports Smith+Nephew's RISE strategy and its ambition to become a global leader in Sports Medicine. Smith+Nephew operates in over 100 countries, reported $5.8 billion in sales in 2024, and employs approximately 17,000 people worldwide.

Smith+Nephew has acquired Integrity Orthopaedics, a company specializing in rotator cuff repair systems, for an initial cash payment of $225 million, with potential performance-based payments of up to $225 million over five years. This acquisition includes Integrity Orthopaedics' Tendon Seam™ technology, which aims to reduce re-tear rates and improve patient outcomes in rotator cuff repairs. The move is part of Smith+Nephew's RISE strategy to enhance its sports medicine portfolio and leadership in the shoulder repair market.

Smith & Nephew announced its acquisition of Integrity Orthopaedics for an initial cash payment of $225 million and potential additional performance-based payments of up to $225 million. Integrity Orthopaedics specializes in the Tendon Seam rotator cuff repair system, which has shown promising early clinical results with low re-tear rates and shorter recovery times. This acquisition is expected to enhance Smith & Nephew's shoulder repair portfolio and contribute to its group trading profit margin by 2028.
SI-BONE Inc (SIBN) reports robust revenue growth and strategic initiatives, setting the stage for continued expansion in 2026 despite anticipated challenges.

Smith+Nephew has finalized its acquisition of Integrity Orthopaedics for up to $450 million. The deal, which includes an initial $225 million cash payment, brings Integrity Orthopaedics' Tendon Seam rotator cuff repair system into Smith+Nephew's portfolio. The Tendon Seam system is designed to address the high failure rates of traditional rotator cuff repairs through patented micro-anchors and improved implantation techniques.